Pfizer Says It Doesn't Belong In Testosterone Gel MDL
Pfizer Inc. argued Wednesday that it had no place in proposed multidistrict litigation targeting makers of prescription testosterone medications that allegedly caused men to suffer heart attacks and strokes, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article